BioCentury
ARTICLE | Clinical News

Elvitegravir regulatory update

July 2, 2012 7:00 AM UTC

Gilead submitted an NDA to FDA for elvitegravir to treat HIV-1 infection in treatment-experienced adults. Last month, EMA accepted for review an MAA for the HIV integrase inhibitor in the indication....